Brief: Adial Provides Business Update Following Comments From US, EU Regulatory Meetings

Adial Pharmaceuticals

11/07/2023 14:07

July 11 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PROVIDES BUSINESS UPDATE FOLLOWING FAVORABLE
COMMENTS FROM
US AND EU REGULATORY MEETINGS
    * ADIAL PHARMACEUTICALS-MADE STRATEGIC DECISION TO FOCUS
EFFORTS
ON U.S. AS U.S. STANDARDS SHOULD TRANSLATE TO ACCEPTANCE IN
OTHER INTERNATIONAL MARKETS
    * ADIAL PHARMACEUTICALS - CURRENT PLANNING ASSUMPTIONS ARE
THAT
ADIAL WILL NEED TO CONDUCT TWO PHASE 3 TRIALS WITH AD04
    * ADIAL - IN ACTIVE DISCUSSIONS WITH POTENTIAL COMMERCIAL
PARTNERS
WHO EXPRESSED INTEREST IN ADVANCING COMMERCIALIZATION IN U.S.,
EUROPEAN MARKETS

Source text for Eikon:  ID:nGNX1020BK 
Further company coverage:  ADIL.O 

 ((reuters.briefs@thomsonreuters.com;))